Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 3, 1999
[Creutzfeldt-Jakob disease and transfusional risk: the point in 1998]S Laperche
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 6, 1998
[Practical repercussions of 3 years of experience of national hemovigilance on the subject of viral complications]S Laperche
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 4, 2004
[Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)]J Pillonel, S Laperche, , et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 1, 2014
[Relevance of safety measures to avoid HTLV transmission by transfusion in 2014]S Laperche, J Pillonel
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 1, 2005
Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT)J Pillonel, S Laperche,
Annales De Biologie Clinique|June 7, 2002
[Sensitivity of HIV infection screening assays in 2001]S Laperche, T D Ly
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|January 1, 1997
[Development of a biological diagnosis for hepatitis C]S Laperche, A M Couroucé
Vox Sanguinis|December 17, 2008
Blood safety strategies for human T-cell lymphotropic virus in EuropeS Laperche, B Worms, J Pillonel, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|July 5, 2017
Occult hepatitis B infection and transfusion-transmission riskD Candotti, L Boizeau, S Laperche
Pageof 7